510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

Vitek Immunodiagnostic Assay System

K921746510(k) TraditionalCleared Jun 16, 199264-day reviewClass I21 CFR 862.1300Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biomerieux Vitek, Inc. · CGJ Radioimmunoassay, Follicle-Stimulating Hormone

Cleared on Jun 16, 1992 after a 64-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled once.

Decided
Jun 16, 1992
Review
64 days
Class
Class I
Product code
CGJ
Recalls
1
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K921746Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 9, 2018Class IIZ-2331-2018Under Investigation by firmInvalid calibration with low calibrator S1 while using the product.

No ancestor or descendant has a Class I recall.

How does its category compare?

All CGJ devices

CGJ Radioimmunoassay, Follicle-Stimulating Hormone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CGJ

FDA has decided no CGJ device since 2007.

Median 510(k) review, days · CGJ

Too few CGJ 510(k)s in any year since 2007 to give a median.

Recalls per year · CGJ

1in 2023

2012: 12016: 12018: 12021: 12023: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CGJ

4in 2025

2011: 12013: 12016: 12017: 22018: 12019: 12020: 32021: 22022: 12023: 32024: 32025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code CGJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—01
20120—10
20130—01
20140—00
20150—00
20160—11
20170—02
20180—11
20190—01
20200—03
20210—12
20220—01
20230—13
20240—03
20250—04
20260—0—
Cite this page

510(k) Report. “K921746: Vitek Immunodiagnostic Assay System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K921746

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026